| Literature DB >> 30488645 |
Batil K Alonazi1,2, Simon S Keller3,4, Nicholas Fallon1, Valerie Adams5, Kumar Das4, Anthony G Marson3, Vanessa Sluming1.
Abstract
OBJECTIVES: Newly diagnosed focal epilepsy (NDfE) is rarely studied, particularly using advanced neuroimaging techniques. Many patients with NDfE experience cognitive impairments, particularly with respect to memory, sustained attention, mental flexibility, and executive functioning. Cognitive impairments have been related to alterations in resting-state functional brain networks in patients with neurological disorders. In the present study, we investigated whether patients with NDfE had altered connectivity in large-scale functional networks using resting-state functional MRI.Entities:
Keywords: brain connectivity; cognitive dysfunction; new-onset seizures; treatment outcome
Mesh:
Year: 2018 PMID: 30488645 PMCID: PMC6346674 DOI: 10.1002/brb3.1168
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Patient clinical data. Age is years. Time between diagnosis and resting‐state functional MRI (Dx > fMRI) is months
| Age | Sex | EEG | MRI Report | Medication | Dx > fMRI | Seizures between Dx & MRI | Neurological History | Treatment outcome | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 18 | M | N | FCD & Hipp R < L | LMT 400 mg | 6 | Multiple FSIA | No neurological history | PS |
| 2 | 37 | F | N | Normal | LMT 1,000 mg | 2 | FTBTC | Syncope followed by concussive seizure | SF |
| 3 | 39 | M | N | Frontal focal gliosis | LMT 100 mg | 7 | No Seizures | 2 FTBTC & brain injury age of 15 | SF |
| 4 | 57 | M | N | FCD | LEV 1,000 mg | 8 | FSIA | FTBTC & pituitary cyst | SF |
| 5 | 43 | F | N | Normal | LEV 1,000 mgs | 1 | FSIA | Headaches & previous seizures | SF |
| 6 | 30 | M | N | Normal | LAM 150 mg | 7 | Single FSIA | No neurological history | SF |
| 7 | 28 | F | N | Normal | LEV 1,000 mg | 5 | No Seizures | FSIA & FTBTC | PS |
| 8 | 37 | M | A | Normal | ZNS 200 mg | 8 | 2 FSIA | FSIA & FTBTC | PS |
| 9 | 30 | M | N | Hippo L < R | LMT 500 mg | 8 | FSIA | Von Willebrand disease | PS |
| 10 | 22 | M | N | Normal | ZNS 150 mg | 1 | No Seizures | FTBTC | SF |
| 11 | 37 | M | N | Normal | LMT 150 mg | 2 | No Seizures | History of FC | SF |
| 12 | 38 | F | N | Multiple WM hypointensity; haemosiderin and suggestive of previous microhaemorrhages | ZNS 250 mg | 5 | FSIA & FTBTC | Previous hypoxic brain injury | SF |
| 13 | 37 | F | N | Normal | ZNS 500 mg | 1 | No Seizures | FSA | SF |
| 14 | 18 | F | N | Normal | LMT 150 mg | 11 | 4 FSIA & FTBTC | No neurological history | PS |
| 15 | 54 | F | N | Normal | LMT 100 mg | 1 | 6 FSIA | FTBTC and history of FC | SF |
| 16 | 41 | F | A | Normal | LEV 500 mg | 5 | FSIA & FTBTC | FTBTC | SF |
| 17 | 25 | F | N | Normal | LMT 200 mg | 3 | FSIA | No neurological history | SF |
| 18 | 18 | M | A | Normal | LMT 50 mg | 2 | FSIA | FTBTC | PS |
| 19 | 56 | M | N | Normal | LMT 150 mg | 1 | No Seizures | FSA & FTBTC | PS |
| 20 | 41 | F | N | Normal | LMT 300 mg | 2 | No Seizures | FSIA & FTBTC | SF |
| 21 | 22 | M | N | R hippo change | LMT 50 mg | 3 | No Seizures | FTBTC | SF |
| 22 | 23 | M | N | Normal | LMT 150 mg | 3 | No Seizures | FTBTC | SF |
| 23 | 20 | F | N | Normal | LMT 100 mg | 1 | No Seizures | No neurological history | PS |
| 24 | 32 | M | N | Right FL gliosis, encephalomalacia & CC atrophy; left posterior gliosis | LEV 1,000 mg | 1 | No Seizures | FTBS & previous brain injury | PS |
| 25 | 38 | F | N | Normal | LEV 1,000 mg | 2 | No Seizures | FTBTC | PS |
| 26 | 28 | M | N | Normal | LMT 150 mg | 1 | No Seizures | 2 FTBTC | SF |
| 27 | 24 | M | N | Normal | Unknown | 2 | No Seizures | No neurological history | SF |
A, abnormal; CPS, complex partial seizure; F, female; FC, febrile convulsions; FCD, focal cortical dysplasia; FSA, focal seizure, aware (formerly simple partial seizure (Fisher et al., 2017)); FSAI, focal seizure awareness impaired (formerly complex partial seizure (Fisher et al., 2017)); FTBTC, focal to bilateral tonic–clonic (formerly generalized tonic–clonic seizure (Fisher et al., 2017)); Hippo, hippocampal volume; L, left; LEV, Levetiracetam; LMT, Lamotrigine; M, male; N, normal; PS, persistent seizures; R, right; SF, seizure free; WM, white matter; ZNS, Zonisamide.
Right hippocampal change was observed on Fluid‐Attenuated Inversion Recovery (FLAIR) MRI only.
Seed regions used to generate resting‐state networks. See Figure 1 for visualization of anatomical location of seeds
| Network | Anatomical region | BA |
|
|
|
|---|---|---|---|---|---|
| Default mode | Medial prefrontal cortex | 10 | 1 | 55 | −3 |
| Posterior parietal cortex | 7 | 1 | −61 | 38 | |
| Sensorimotor | Primary motor area | 4 | 0 | −31 | 67 |
| Precentral gyrus, left | 6 | −55 | −12 | 29 | |
| Precentral gyrus, right | 6 | 56 | −10 | 29 | |
| Salience | Anterior cingulate gyrus | 32 | 0 | 22 | 35 |
| Anterior insula, left | 13 | −44 | 13 | 1 | |
| Anterior insula, right | 13 | 47 | 14 | 0 | |
| Fronto‐parietal | Intraparietal sulcus, left | 39 | −46 | −58 | 49 |
| Intraparietal sulcus, right | 39 | 52 | −52 | 45 | |
| Language | Posterior superior temporal gyrus, left | 22 | −57 | −47 | 15 |
| Posterior superior temporal gyrus, right | 22 | 59 | −42 | 13 | |
| Inferior frontal gyrus (pars triangularis), left | 45 | −51 | 26 | 2 | |
| Inferior frontal gyrus (pars triangularis), right | 45 | 54 | 28 | 1 |
Figure 1Location of seeds for each resting‐state network. See Table 2 for anatomical locations and coordinates
Figure 2Lesions identified in the present study (see Table 1 for corresponding information). Patient 1 (P1): mesial temporal focal cortical dysplasia and atrophy of ipsilateral hippocampal head on T1‐weighted (left) and T2‐FLAIR (right) images; P3: orbitofrontal gliosis on T1‐weighted (left) and T2‐FLAIR (right) images; P4: focal cortical dysplasia of middle frontal gyrus on T2‐FLAIR (left) and T2‐weighted (right) images; P9: unilateral hippocampal atrophy on T1‐weighted (left) and T2‐weighted (right) images; P12: temporal lobe white matter alteration on T2‐weighted (left) and T2‐FLAIR (right) images; P24: frontal lobe gliosis and encephalomalacia, corpus callosum atrophy and contrecoup posterior gliosis on T2‐FLAIR (left) and T1‐weighted (right images). Patient 21 (slight unilateral hippocampal alteration) not illustrated. Images are neurological convention (right = right)
Figure 3Resting‐state functional networks shown separately for controls (C) and patients (P). Regions correlated (orange) and anticorrelated (purple) with seeds are indicated. Specific seeds used to generate networks indicated here include medial prefrontal cortex (default mode), primary motor area (sensorimotor), anterior cingulate gyrus (salience), left intraparietal sulcus (fronto‐parietal), and left inferior frontal gyrus (language). Networks were reproducibly reconstructed using the alternative seeds shown in Figure 1. Note the visual difference between controls and patients in the fronto‐parietal attentional network
Figure 4Significantly reduced functional connectivity within the fronto‐parietal attentional network in patients relative to controls (left intraparietal sulcus seed). Hypoconnectivity in all patients relative to controls is projected onto a 3D rendering (a) and axial sections (b) to illustrate anatomical locations. The spatial distribution of hypoconnectivity in all patients (c) and patients with normal MRI scans (d) is compared using glass brain projections. The corresponding information for each cluster is provided in Tables 3 and 4
Second‐level results: significantly reduced functional connectivity between intraparietal sulcus seeds and the rest of the brain in all patients relative to controls. Regions are illustrated in Figure 4
| Seed | Anatomical regions | Peak | Cluster | Cluster | Peak |
|---|---|---|---|---|---|
| Left |
| 62, −12, −28 | 867 | 0.004 | 0.00004 |
|
| −44, −56, 22 | 865 | 0.006 | 0.00001 | |
|
| −10, 24, 52 | 672 | 0.007 | <0.00001 | |
|
| −60, −44, −02 | 650 | 0.007 | 0.0002 | |
| Precuneus, posterior cingulate gyrus | −02, −52, 20 | 484 | 0.002 | 0.0004 | |
| Right |
| 54, −30, −16 | 600 | 0.04 | 0.0008 |
|
| −20, 40, 18 | 643 | 0.03 | 0.00008 | |
|
| −38, −86, −36 | 1,101 | 0.004 | 0.0008 |
Second‐level results: significantly reduced functional connectivity between intraparietal sulcus seeds and the rest of the brain in nonlesional patients only relative to controls
| Seed | Anatomical regions | Peak | Cluster | Cluster | Peak |
|---|---|---|---|---|---|
| Left |
| 62, −12, −28 | 583 | 0.007 | 0.00007 |
|
| −44, −56, 22 | 570 | 0.009 | 0.00002 | |
|
| −10, 24, 52 | 509 | 0.01 | <0.00001 | |
|
| −60, −44, −02 | 326 | 0.03 | 0.0001 | |
| Right |
| −20, 40, 18 | 451 | 0.05 | 0.0001 |